AGP Executive Report
Last update: 16 minutes agoCorporate Expansion: InterCure says it completed the first tranche (50%) of its Botanico acquisition and is now reviewing regulated U.S. medical cannabis opportunities after federal rescheduling, adding U.S. genetics, premium brands and AI-driven tech. Workplace Safety Tech: Cannabix Technologies deployed its Marijuana Breath Test with a major Québec heavy-industry operator via Alco Prevention Canada, aiming to support post-incident and reasonable-cause testing. Retail Growth: High Tide secured C$40M in new senior secured credit facilities and agreed to buy Northern Helm, adding four Ontario stores and pushing its Canadian footprint higher. M&A in Cannabis: Vireo Growth inked a definitive deal to acquire C21, expanding Nevada presence to about 15 dispensaries and boosting cultivation/manufacturing capacity. Medical/Healthcare Capital: Splash Beverage Group invested CDN$300,000 in Avicanna to support its shift toward cannabinoid healthcare and biopharma development. International Drug Enforcement (Nigeria): NDLEA reports multiple major busts, including cocaine-soaked shirts/towels from Brazil and large cannabis seizures in Lagos and beyond. Global Drug Trends: UNODC says synthetic drug markets in East and South-East Asia kept expanding in 2025, with meth and ketamine seizures hitting record levels.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
